(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 11.14% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.5%.
Caredx's revenue in 2025 is $333,785,000.On average, 3 Wall Street analysts forecast CDNA's revenue for 2025 to be $20,560,403,512, with the lowest CDNA revenue forecast at $20,457,145,062, and the highest CDNA revenue forecast at $20,710,995,679.
In 2026, CDNA is forecast to generate $23,529,402,643 in revenue, with the lowest revenue forecast at $23,445,155,277 and the highest revenue forecast at $23,613,650,010.